LINEZOLID CIP linezolid 600 mg film-coated tablet bottle

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

linezolid, Quantity: 600 mg

Disponible desde:

Cipla Australia Pty Ltd

Designación común internacional (DCI):

Linezolid

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: maize starch; hyprolose; sodium starch glycollate type A; magnesium stearate; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000

Vía de administración:

Oral

Unidades en paquete:

20, 100

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

LINEZOLID CIP is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,LINEZOLID CIP is active against Gram-positive bacteria only.,LINEZOLID CIP has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram- negative pathogen is documented or suspected.

Resumen del producto:

Visual Identification: White to off-white, oval shaped, biconvex, film-coated tablets, debossed on one side "CL".; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2017-01-24